BAKER BROTHERS ADVISORS LLC
A privately owned hedge fund sponsor. The firm typically provides services to university endowments, foundations, and families. It invests in the public equity markets of the United States. The firm primarily invests in life science companies. Baker Bros Advisors was founded in 2000 and is based in New York City.
BAKER BROTHERS ADVISORS LLC
Founded:
2000-01-01
Status:
Active
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-09 | DBV Technologies | Baker Brothers Advisors LLC investment in Post-IPO Equity - DBV Technologies | 181 M EUR |
| 2019-12-19 | FORMA Therapeutics | Baker Brothers Advisors LLC investment in Series D - FORMA Therapeutics | 100 M USD |
| 2019-07-08 | IGM Biosciences | Baker Brothers Advisors LLC investment in Series C - IGM Biosciences | 102 M USD |
| 2019-02-26 | Hookipa Pharma | Baker Brothers Advisors LLC investment in Series D - Hookipa Pharma | 37.4 M USD |
| 2019-01-03 | Cabaletta Bio | Baker Brothers Advisors LLC investment in Series B - Cabaletta Bio | 50 M USD |
| 2018-11-08 | Cabaletta Bio | Baker Brothers Advisors LLC investment in Series A - Cabaletta Bio | 38 M USD |
| 2018-03-23 | Omniox | Baker Brothers Advisors LLC investment in Series D - Omniox | N/A |
| 2018-02-01 | Kiniksa Pharmaceuticals | Baker Brothers Advisors LLC investment in Series C - Kiniksa Pharmaceuticals | 200 M USD |
| 2017-12-11 | Hookipa Pharma | Baker Brothers Advisors LLC investment in Series C - Hookipa Pharma | 60 M USD |
| 2017-03-01 | Kiniksa Pharmaceuticals | Baker Brothers Advisors LLC investment in Series B - Kiniksa Pharmaceuticals | 40 M USD |